DOJ: Trump admin is reviewing mifepristone cases, dropping EMTALA case
Google AI sez:
EMTALA requires that anyone coming to an emergency department requesting evaluation or treatment of a medical condition, receives a medical screening examination. If they have an emergency medical condition, the hospital must provide stabilizing treatment, regardless of the patient's insurance status or ability to pay.Sep 11, 2024
The Emergency Medical Treatment and Labor Act (EMTALA)
DOJ: Trump admin is reviewing mifepristone cases, dropping EMTALA case
DOJ has until May 5 to say whether it is changing position in a challenge to mifepristone access. UPDATE: DOJ plans to dismiss its EMTALA case against Idaho.
Chris Geidner
Mar 04, 2025

The Trump administration began weighing in on abortion-related litigation this week. ... The Justice Department asked for and received a two-month deadline extension in the still-ongoing mifepristone access case before U.S. District Judge Matt Kacsmaryk as part of a review by the Trump administration of “mifepristone-related litigation.”
Although the Justice Department did not announce any change in position in the Northern District of Texas case in
its Monday filing, the DOJ lawyers asked for the two-month extension, in part, so “the new Administration” can “familiarize themselves with the issues in this case,” specifying that they were “seeking” the extension here and in “other mifepristone-related litigation.”

Reviewing several other mifepristone-related cases, however, Law Dork found no similar filings from “the new Administration” as of publication Tuesday. (Let me know if I missed something!)
The request is, if nothing else, a concerning sign that merits close attention.
{snip}
https://storage.courtlistener.com/recap/gov.uscourts.txnd.370067/gov.uscourts.txnd.370067.238.0_1.pdf